The main goals of Ulcerative Colitis (UC) treatment are to both induce and maintain the
clinical and endoscopic remission of disease, reduce the incidence of complications such as …

Ulcerative colitis (UC) is a relapsing and remitting inflammatory disease of the colon with a
variable course. Despite advances in treatment, only approximately 40% of patients achieve …

Ulcerative colitis (UC) is a chronic and progressive inflammatory disorder that affects the
colon. The advent of advanced therapies such as biologic agents and small molecules has …

Introduction Despite advances in the medical management of ulcerative colitis (UC), a
subgroup of patients does not respond to currently available therapies. A number of novel …

Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids.
Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded …

Increased knowledge of the intricate pathogenesis of ulcerative colitis has triggered an
advance in drug development during the past two decades, resulting in the advent of several …

Background: Patient care in ulcerative colitis (UC) remains challenging despite an array of
established treatment options and emerging new therapies. The management of UC therapy …

Induction and maintenance of remission, mucosal healing, the avoidance of surgical
intervention, and decreasing the likelihood of cancer developing are the primary therapeutic …

The incidence and prevalence of ulcerative colitis are increasing globally. Although the
exact cause and pathogenesis of this disease is unclear, research has led to a better …

Ulcerative colitis (UC) is a chronic idiopathic inflammatory disease of the gastrointestinal
tract that affects the mucosal lining of the colon. Recent epidemiological data show that its …